INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI) investors concerning the Company and its officers’ possible violations of federal securities laws.

On May 8, 2020, ICU announced that it was “voluntarily recalling one single lot of Lactated Ringer’s Injection, USP, . . . due to the presence of particulate matter identified as iron oxide.”

On this news, ICU’s stock price fell $19.26 per share, or nearly 9%, to close at $198.10 per share on May 8, 2020, on unusually heavy trading volume.

If you purchased ICU securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], toll-free at [phone], or by email to [e-mail], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.